News
- Author:
- Becky McCall
Publish date: March 7, 2025
The ASTRO study also showed that subcutaneous induction is consistent with intravenous induction of guselkumab in ulcerative colitis.
News
- Author:
- Becky McCall
Publish date: March 4, 2025
Current treatment options for UC remain limited, especially for patients with an inadequate response to biologics or small molecules.
News
- Author:
- Becky McCall
Publish date: March 4, 2025
The AI model addresses longstanding limitations of capsule endoscopy interpretation, including time-consuming readings and inter-observer variabili...
News
- Author:
- Becky McCall
Publish date: February 27, 2025
Patients with Crohn’s disease who responded to anti-TNF therapies had 138 different proteins from those of anti-TNF nonresponders.
News
- Author:
- Becky McCall
Publish date: February 27, 2025
“Showing that a diet is associated with an outcome is not the same as knowing that changing a diet will reduce the risk,” said Dr James Lindsay.
News
- Author:
- Becky McCall
Publish date: November 5, 2024
Almost all patients in the biologic-inadequate response group had previously received at least one anti–tumor necrosis factor agent, and around 15%...
News
- Author:
- Becky McCall
Publish date: November 5, 2024
Patients with IBD had a moderately increased risk for T1D and higher odds of having prior T1D than the general population.
News
- Author:
- Becky McCall
Publish date: October 30, 2024
This is the first prospective study of this particular level of UPFs in people with Crohn’s disease who are in remission.
News
- Author:
- Becky McCall
Publish date: October 29, 2024
Treatment with cendakimab also improved key endoscopic and histologic features, even in patients who had an inadequate response or intolerance to s...
News
- Author:
- Becky McCall
Publish date: October 29, 2024
“The key questions here relate to why are these systems underperforming in the proximal colon, and how can we improve this?” said Dr. David Graham....
News
- Author:
- Becky McCall
Publish date: October 18, 2024
Successful PERT is defined as the resolution of nutritional deficiencies and relief of symptoms and signs associated with insufficiency.
News
- Author:
- Becky McCall
Publish date: October 15, 2024
At the 24-month follow-up, 11 patients were still insulin-free while maintaining A1c levels below 7.5%.
News
- Author:
- Becky McCall
Publish date: October 14, 2024
“If the doctors are moving, they’re much more likely to promote it, and if they’re eating well, they’re much more likely to be able to be evangelis...
News
- Author:
- Becky McCall
Publish date: October 2, 2024
The guideline recognizes that individuals with type 2 diabetes or obesity with additional metabolic risk factor(s) are at a higher risk for MASLD w...
News
- Author:
- Becky McCall
Publish date: September 13, 2024
A dual-pathway, oral weight loss drug resulted in up to 13% body weight loss, finds Phase 1 study.
